LON:MTFB Motif Bio (MTFB) Share Forecast, Price & News GBX 0.50 0.00 (0.00%) (As of 07/29/2020) Add Compare Share Share Today's Range 0.50▼ 0.5050-Day Range 0.50▼ 0.5052-Week Range 0.03▼ 3.20VolumeN/AAverage Volume33.38 million shsMarket Capitalization£3.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Motif Bio (LON:MTFB) StockMotif Bio plc does not have any significant operations. It intends to identify a reverse takeover or other strategic transaction. Previously, the company was engaged in developing and commercializing pharmaceutical formulations. Motif Bio plc was incorporated in 2014 and is based in New York, New York.Read More MTFB Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MTFB Stock News HeadlinesMay 27, 2023 | lse.co.ukMTFB.L Regulatory NewsApril 22, 2023 | theguardian.comThe Christian history of the Green Man motifSeptember 25, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.November 27, 2022 | finance.yahoo.comOchre Bio Announces Participation in Upcoming ConferencesSeptember 1, 2022 | investing.comMTFB_old Historical DataJanuary 23, 2022 | fool.comMotif Bio plc ADRs(MTFB)October 26, 2021 | finance.yahoo.comMTFB: Additional Data for Iclaprim Presented at ESCMID/ASM…October 26, 2021 | finance.yahoo.comMTFB: REVIVE-1 Results Published in Clinical Infectious DiseasesSeptember 25, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...April 11, 2021 | markets.businessinsider.comMotif Bio PLC : Update re proposed Reverse TakeoverFebruary 10, 2021 | marketwatch.comOsteomyelitis Drugs Market potential growth, share, demand and analysis of key players – research forecasts to 2028January 5, 2021 | lse.co.ukMotif Bio Plc Regulatory NewsDecember 7, 2020 | in.finance.yahoo.comMOTIF BIO PLC LS -,0001 (7MB.BE)December 6, 2020 | marketwatch.comOsteomyelitis Drugs Market 2020-2028 Research Report| Know The Growth Factors and Future ScopeOctober 12, 2020 | lse.co.ukCash Shell Motif Bio Swings To Interim Loss On Derivative LiabilitiesJune 10, 2020 | www.bloomberg.comMotif Bio Phase 3 Clinical Trial Finishes Patient Treatment PhaseMay 23, 2020 | www.bloomberg.comMotif Bio PLC, Spero Therapeutics, Inc. and Vical Incorporated Join Antimicrobials Working GroupDecember 27, 2019 | www.lse.co.ukMotif Bio Share ChatNovember 30, 2019 | news.yahoo.comHedge Funds Have Never Been More Bullish On Motif Bio plc (MTFB)November 26, 2019 | seekingalpha.comMotif Bio to file for voluntary delistingNovember 26, 2019 | finance.yahoo.comMotif Bio plc Announces Voluntary Delisting from the Nasdaq Capital MarketOctober 10, 2019 | www.lse.co.ukMotif Bio Meeting With US FDA Confirms Need For Another iclaprim TrialJuly 15, 2019 | seekingalpha.comMotif Bio submits Type B meeting request to FDAJune 6, 2019 | seekingalpha.comHOME, CLDR and MIK among premarket losersJune 6, 2019 | seekingalpha.comMotif Bio not quite there with iclaprim NDA; shares down 35% premarketMay 22, 2019 | seekingalpha.comMotif Bio to evaluate iclaprim in ophthalmology; shares up 8% premarketMay 3, 2019 | finance.yahoo.comMotif Bio meeting with U.S. FDA held as plannedSee More Headlines Receive MTFB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Motif Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:MTFB CUSIPN/A CIKN/A Webwww.motifbio.com Phone609-608-0032FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio4.39 Quick Ratio3.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 15.29 per share Price / Cash Flow0.03 Book ValueGBX 15.50 per share Price / Book0.03Miscellaneous Outstanding Shares654,991,000Free FloatN/AMarket Cap£3.27 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Jonathan E. Gold (Age 48)Pres, Chief Bus. Officer & Exec. Director Comp: $618.39kLaurie DoyleHead of Investor Relations & Corp. CommunicationsMr. Robert Dickey IV (Age 65)M.B.A., Advisor Liam O'DonoghueCompany Sec.Ms. Lynda BerneConsultant - Commercial & Bus. StrategyDr. James S. MacDonald (Age 89)Toxicology Consultant Dr. Robert J. McCormack Ph.D.Regulatory ConsultantDr. Catherine D. Strader (Age 66)Drug Devel. Consultant Mr. Mark VanArendonkConsultant of Chemistry, Manufacturing & ControlsMore ExecutivesKey CompetitorsFusion AntibodiesLON:FABReNeuron GroupLON:RENEPhysiomicsLON:PYCNuformixLON:NFXSalvaRx GroupLON:SALVView All Competitors MTFB Stock - Frequently Asked Questions How have MTFB shares performed in 2023? Motif Bio's stock was trading at GBX 0.50 at the beginning of the year. Since then, MTFB stock has increased by 0.0% and is now trading at GBX 0.50. View the best growth stocks for 2023 here. What other stocks do shareholders of Motif Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Motif Bio investors own include Hawkins (HWKN), CA (CA), Sirius Minerals (SXX), Egdon Resources (EDR), BlackRock (BLK), Endologix (ELGX), Global Blood Therapeutics (GBT), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG) and Aegean Marine Petroleum Network (ANW). What is Motif Bio's stock symbol? Motif Bio trades on the London Stock Exchange (LON) under the ticker symbol "MTFB." How do I buy shares of Motif Bio? Shares of MTFB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Motif Bio's stock price today? One share of MTFB stock can currently be purchased for approximately GBX 0.50. How much money does Motif Bio make? Motif Bio (LON:MTFB) has a market capitalization of £3.27 million. How can I contact Motif Bio? Motif Bio's mailing address is One Tudor Street, LONDON, EC4Y 0AH, United Kingdom. The official website for the company is www.motifbio.com. The company can be reached via phone at 609-608-0032. This page (LON:MTFB) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motif Bio plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.